Advances in the pathogenesis and pharmacotherapy of acute stress disorder

Wang Xin-Yue, Wang Tian and Fu Feng-Hua *

School of Pharmacy, Yantai University, Yantai 264005, China.
 
Review
International Journal of Science and Research Archive, 2022, 05(01), 016–021.
Article DOI: 10.30574/ijsra.2022.5.1.0031
Publication history: 
Received on 23 December 2021; revised on 24 January 2022; accepted on 26 January 2022
 
Abstract: 
Acute stress disorder (ASD) is a kind of mental disease caused by trauma, which will bring heavy burdens to patients themselves, their family, their work and their lives. Once a person who has suffered a trauma develops post-traumatic stress disorder (PTSD), the quality of life of patients will be overall impaired. It is found that the occurrence of stress disorder is related to the overactivation of hypothalamus pituitary adrenal axis (HPA axis). The most commonly used medications for ASD are recommended medications for PTSD, including serotonin reuptake inhibitors (SRIs), second-generation antipsychotics, benzodiazepines, beta blockers, and others. The purpose of this article is to systematically organize and review the possible mechanisms of stress disorder and drugs for treatment of ASD.
 
Keywords: 
Acute stress disorder; Stress; PTSD; Glucocorticoid
 
Full text article in PDF: 
 
Copyright information: 

Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0